ArticleFrontiers in oncology2024

CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer.

Xiaolin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.